| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |